Roche says it is thoughtful on token use for AI, shelves a drug from Carmot buy
Roche has offered some insight into how it is using AI, from drug discovery to token use. AI has already contributed to “a significant increase in new molecules” in its pipeline, CEO Thomas Schinecker said ...
Thomas Schinecker, CEO Roche Group July 23, 2026 07:03 AM EDT R&DAIPharma Roche says it is thoughtful on token use for AI, shelves a drug from Carmot buy Elizabeth Cairns Senior biopharma journalist Roche has offered some insight into how it is using AI, from drug discovery to token use. AI has already contributed to “a significant increase … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that